Request Your Free White Paper Now:

"Leveraging Decentralized Clinical Trial Strategies to Reduce Health Care Disparities"

Despite growing awareness of the varying efficacy and safety profiles of therapeutics among patients from diverse backgrounds, minority populations continue to be significantly underrepresented in current clinical trials.

To successfully treat and/or prevent disease states, clinical trial patient populations must accurately reflect the population inflicted with the condition. Ultimately, diversity in clinical trials is fundamental to reducing disparities and increasing access to effective health care. From this white paper you’ll uncover: 

• Root causes of underrepresentation 
• Strategies/frameworks from regulatory bodies to amend imbalances
• Decentralization methods to enable diversity 

Offered Free by: PPD
See All Resources from: PPD